Humoral immunogenicity of SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A CIBMTR and BMT CTN study Meeting Abstract


Authors: Riches, M. L.; Hill, J. A.; Martens, M.; Auletta, J. J.; Baluch, A.; Bhavsar, K.; Brown, J.; Dhodapkar, M. V.; DiFronzo, N.; Howard, A.; Ibrahim, U.; Nakamura, R.; Peyton, K.; Shahid, Z.; Sharon, E.; Spahn, A.; Toor, A. A.; Waldvogel, S.; Westervelt, P.; Young, J. A. H.; Perales, M. A.; Horowitz, M. M.
Abstract Title: Humoral immunogenicity of SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A CIBMTR and BMT CTN study
Meeting Title: 2022 Tandem Meetings of ASTCT and CIBMTR
Journal Title: Transplantation and Cellular Therapy
Volume: 28
Issue: 3 Suppl.
Meeting Dates: 2022 Apr 23-26
Meeting Location: Salt Lake City, UT
ISSN: 2666-6375
Publisher: Elsevier Inc.  
Date Published: 2022-03-01
Start Page: S372
End Page: S373
Language: English
DOI: 10.1016/S2666-6367(22)00635-2
PROVIDER: manual
Notes: Meeting Abstract: 475 -- Located within the section named "Poster Session - Infectious Diseases And Cytotoxic T Lymphocytes"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Miguel-Angel Perales
    914 Perales